Myriad Genetics, Inc. (MYGN)
$23.60
0.14 (+0.60%)
| CAPS Rating |
|
|---|---|
| Open | $23.47 |
| Previous Close | $23.46 |
| Daily Range | $23.20 - $23.72 |
| 52-Week Range | $22.38 - $47.08 |
| Market Cap | $2.27B |
| P/E Ratio | 15.54 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,211,965 |
| Average Daily Volume | 1,836,000 |
How do you think MYGN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MYGN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MYGN News and Commentary
- 3 Stocks Hitting Low Notes – The Motley Fool
- UPDATE 1-Myriad Genetics Q1 trails estimates; shares fall – Reuters
- Lawsuit against gene patents can proceed - US judge – Reuters
- 2 Stocks Hitting Low Notes – The Motley Fool
- Hey, Sequenom, That's Great, But ... – The Motley Fool
- Takeover Likely? Management Says No! – The Motley Fool
- 5 Stocks That Laugh at Wall Street – The Motley Fool
- Wednesday's Biggest Stock Stars – The Motley Fool
- This One's Growing Through the Recession – The Motley Fool
- 2 Stocks Hitting Low Notes – The Motley Fool
- These 6 Winners Won't Send You to Prison – The Motley Fool
- The Wrong Way to Invest in the Right Stocks – The Motley Fool
- The World's 10 Best Stocks – The Motley Fool
- 4-Star Stocks Poised to Pop: Myriad Genetics – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- Diagnosing a Personalized Partnership – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- Why Dividends Really Make a Difference – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool


RSS Headlines
Fool UK